These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 39185522)

  • 1. Alzheimer's disease protective allele of
    Zhao X; Li Y; Zhang S; Sudwarts A; Zhang H; Kozlova A; Moulton MJ; Goodman LD; Pang ZP; Sanders AR; Bellen HJ; Thinakaran G; Duan J
    medRxiv; 2024 Aug; ():. PubMed ID: 39185522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clusterin secreted from astrocyte promotes excitatory synaptic transmission and ameliorates Alzheimer's disease neuropathology.
    Chen F; Swartzlander DB; Ghosh A; Fryer JD; Wang B; Zheng H
    Mol Neurodegener; 2021 Jan; 16(1):5. PubMed ID: 33517893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular clusterin interacts with brain isoforms of the bridging integrator 1 and with the microtubule-associated protein Tau in Alzheimer's disease.
    Zhou Y; Hayashi I; Wong J; Tugusheva K; Renger JJ; Zerbinatti C
    PLoS One; 2014; 9(7):e103187. PubMed ID: 25051234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clusterin Is Required for β-Amyloid Toxicity in Human iPSC-Derived Neurons.
    Robbins JP; Perfect L; Ribe EM; Maresca M; Dangla-Valls A; Foster EM; Killick R; Nowosiad P; Reid MJ; Polit LD; Nevado AJ; Ebner D; Bohlooly-Y M; Buckley N; Pangalos MN; Price J; Lovestone S
    Front Neurosci; 2018; 12():504. PubMed ID: 30090055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astrocytic response mediated by the CLU risk allele inhibits OPC proliferation and myelination in a human iPSC model.
    Liu Z; Chao J; Wang C; Sun G; Roeth D; Liu W; Chen X; Li L; Tian E; Feng L; Davtyan H; Blurton-Jones M; Kalkum M; Shi Y
    Cell Rep; 2023 Aug; 42(8):112841. PubMed ID: 37494190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease risk allele of
    Kozlova A; Zhang S; Sudwarts A; Zhang H; Smirnou S; Sun X; Stephenson K; Zhao X; Jamison B; Ponnusamy M; He X; Pang ZP; Sanders AR; Bellen HJ; Thinakaran G; Duan J
    Res Sq; 2024 May; ():. PubMed ID: 38826437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's risk variants in the clusterin gene are associated with alternative splicing.
    Szymanski M; Wang R; Bassett SS; Avramopoulos D
    Transl Psychiatry; 2011; 1(7):e18-. PubMed ID: 21892414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astrocyte-derived clusterin suppresses amyloid formation in vivo.
    Wojtas AM; Sens JP; Kang SS; Baker KE; Berry TJ; Kurti A; Daughrity L; Jansen-West KR; Dickson DW; Petrucelli L; Bu G; Liu CC; Fryer JD
    Mol Neurodegener; 2020 Nov; 15(1):71. PubMed ID: 33246484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variant rs11136000 upregulates clusterin expression and reduces Alzheimer's disease risk.
    Ma J; Qiu S
    Front Neurosci; 2022; 16():926830. PubMed ID: 36033622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal ROS-induced glial lipid droplet formation is altered by loss of Alzheimer's disease-associated genes.
    Moulton MJ; Barish S; Ralhan I; Chang J; Goodman LD; Harland JG; Marcogliese PC; Johansson JO; Ioannou MS; Bellen HJ
    Proc Natl Acad Sci U S A; 2021 Dec; 118(52):. PubMed ID: 34949639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variation in clusterin and risk of dementia and ischemic vascular disease in the general population: cohort studies and meta-analyses of 362,338 individuals.
    Nordestgaard LT; Tybjærg-Hansen A; Rasmussen KL; Nordestgaard BG; Frikke-Schmidt R
    BMC Med; 2018 Mar; 16(1):39. PubMed ID: 29534716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudoexfoliation and Alzheimer's associated CLU risk variant, rs2279590, lies within an enhancer element and regulates CLU, EPHX2 and PTK2B gene expression.
    Padhy B; Hayat B; Nanda GG; Mohanty PP; Alone DP
    Hum Mol Genet; 2017 Nov; 26(22):4519-4529. PubMed ID: 28973302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of clusterin gene (CLU/APOJ) polymorphism in Alzheimer's disease patients and in normal cohorts from Russian populations].
    Golenkina SA; Gol'tsov AIu; Kuznetsova IL; Grigorenko AP; Andreeva TV; Reshetov DA; Kunizheva SS; Shagam LI; Morozova IIu; Goldenkova-Pavlova IV; Shimshilashvili Kh; Viacheslavova AO; Faskhutdinova G; Gareeva AÉ; Zaĭnullina AG; Khusnutdinova ÉK; Puzyrev VP; Stepanov VA; Kolotvin AV; Samokhodskaia LM; Selezneva ND; Gavrilova SI; Rogaev EI
    Mol Biol (Mosk); 2010; 44(4):620-6. PubMed ID: 20873220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clusterin in Alzheimer's Disease: Mechanisms, Genetics, and Lessons From Other Pathologies.
    Foster EM; Dangla-Valls A; Lovestone S; Ribe EM; Buckley NJ
    Front Neurosci; 2019; 13():164. PubMed ID: 30872998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Glia-Neuron Lactate Shuttle and Elevated ROS Promote Lipid Synthesis in Neurons and Lipid Droplet Accumulation in Glia via APOE/D.
    Liu L; MacKenzie KR; Putluri N; Maletić-Savatić M; Bellen HJ
    Cell Metab; 2017 Nov; 26(5):719-737.e6. PubMed ID: 28965825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered glia-neuron communication in Alzheimer's Disease affects WNT, p53, and NFkB Signaling determined by snRNA-seq.
    Soelter TM; Howton TC; Clark AD; Oza VH; Lasseigne BN
    Cell Commun Signal; 2024 Jun; 22(1):317. PubMed ID: 38849813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered Glia-Neuron Communication in Alzheimer's Disease Affects WNT, p53, and NFkB Signaling Determined by snRNA-seq.
    Soelter TM; Howton TC; Clark AD; Oza VH; Lasseigne BN
    bioRxiv; 2024 May; ():. PubMed ID: 38076822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin.
    Deming Y; Xia J; Cai Y; Lord J; Holmans P; Bertelsen S; Holtzman D; Morris JC; Bales K; Pickering EH; Kauwe J; Goate A; Cruchaga C;
    Neurobiol Aging; 2016 Jan; 37():208.e1-208.e9. PubMed ID: 26545630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-type-specific regulation of APOE and CLU levels in human neurons by the Alzheimer's disease risk gene SORL1.
    Lee H; Aylward AJ; Pearse RV; Lish AM; Hsieh YC; Augur ZM; Benoit CR; Chou V; Knupp A; Pan C; Goberdhan S; Duong DM; Seyfried NT; Bennett DA; Taga MF; Huynh K; Arnold M; Meikle PJ; De Jager PL; Menon V; Young JE; Young-Pearse TL
    Cell Rep; 2023 Aug; 42(8):112994. PubMed ID: 37611586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the Role of CLU in the Pathogenesis of Alzheimer's Disease.
    Uddin MS; Kabir MT; Begum MM; Islam MS; Behl T; Ashraf GM
    Neurotox Res; 2021 Dec; 39(6):2108-2119. PubMed ID: 32820456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.